- Home
- BNGO vs IBIO Comparison
BNGO vs IBIO Comparison
Compare BNGO & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNGO
- IBIO
- Stock Information
- Founded
- BNGO 2003
- IBIO 2008
- Country
- BNGO United States
- IBIO United States
- Employees
- BNGO N/A
- IBIO N/A
- Industry
- BNGO Biotechnology: Laboratory Analytical Instruments
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- BNGO Industrials
- IBIO Health Care
- Exchange
- BNGO Nasdaq
- IBIO Nasdaq
- Market Cap
- BNGO 24.3M
- IBIO 24.3M
- IPO Year
- BNGO 2018
- IBIO N/A
- Fundamental
- Price
- BNGO $4.09
- IBIO $0.89
- Analyst Decision
- BNGO Buy
- IBIO Strong Buy
- Analyst Count
- BNGO 4
- IBIO 3
- Target Price
- BNGO $7.00
- IBIO $4.87
- AVG Volume (30 Days)
- BNGO 215.0K
- IBIO 717.9K
- Earning Date
- BNGO 05-07-2025
- IBIO 05-12-2025
- Dividend Yield
- BNGO N/A
- IBIO N/A
- EPS Growth
- BNGO N/A
- IBIO N/A
- EPS
- BNGO N/A
- IBIO N/A
- Revenue
- BNGO $30,776,000.00
- IBIO $375,000.00
- Revenue This Year
- BNGO $0.53
- IBIO $36.00
- Revenue Next Year
- BNGO $8.46
- IBIO $33.33
- P/E Ratio
- BNGO N/A
- IBIO N/A
- Revenue Growth
- BNGO N/A
- IBIO 650.00
- 52 Week Low
- BNGO $2.68
- IBIO $1.03
- 52 Week High
- BNGO $72.60
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- BNGO 52.17
- IBIO 18.58
- Support Level
- BNGO $4.02
- IBIO $1.08
- Resistance Level
- BNGO $5.22
- IBIO $1.33
- Average True Range (ATR)
- BNGO 0.49
- IBIO 0.37
- MACD
- BNGO 0.21
- IBIO -0.21
- Stochastic Oscillator
- BNGO 53.94
- IBIO 0.55
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.